TEER is technically feasible for treating acute severe mitral regurgitation caused by papillary muscle rupture following AMI, and can effectively reduce mitral regurgitation and improve hemodynamic status in selected high-risk patients in the short term.
Key Findings
Results
The study population consisted of 12 patients with AMI complicated by papillary muscle rupture and severe mitral regurgitation who underwent TEER.
Mean age was 67.4 years, with 10 males and 2 females.
11 of 12 patients were diagnosed with ST-segment elevation myocardial infarction.
11 of 12 cases involved complete rupture of the posteromedial papillary muscle.
Cardiogenic shock was present in 10 of 12 patients.
The median Society of Thoracic Surgeons (STS) score was 51.9%, indicating extremely high surgical risk.
Results
TEER achieved procedural success in all 12 patients, with mitral regurgitation reduced to grade ≤2+ immediately post-procedure.
Procedural success was defined as successful grasping of the anterior and posterior mitral leaflets and reduction of mitral regurgitation to grade 2+ or less.
100% procedural success rate (12/12 patients).
All patients had mitral regurgitation reduced to ≤2+ immediately after the procedure.
No device- or procedure-related complications occurred during the perioperative period.
Results
Eleven of 12 patients survived to hospital discharge following TEER.
In-hospital survival rate was 91.7% (11/12 patients).
No device- or procedure-related complications occurred during the perioperative period.
The study was conducted at Xiamen Cardiovascular Hospital affiliated to Xiamen University from December 2021 to October 2024.
Results
During 30-day follow-up after TEER, 2 patients died and 1 was readmitted for acute heart failure.
Follow-up period was 30 days post-procedure.
2 patients died during the follow-up period.
1 patient was readmitted due to acute heart failure.
At the 30-day follow-up, 9 patients maintained a mitral regurgitation grade of ≤2+.
Methods
The study was a retrospective case series examining the clinical feasibility, early efficacy, and safety of TEER in patients with AMI-complicated papillary muscle rupture.
Retrospective analysis of 12 patients treated at a single center.
Data collected included demographic characteristics, diagnostics and treatment processes, and in-hospital outcomes.
Patients were followed up for 30 days post-procedure to evaluate survival status and severity of mitral regurgitation.
The authors note findings necessitate further validation through larger-scale multicenter studies and long-term follow-up.
Chen X, Lin Y, Su M, Chen X, Meng F, Huang H, et al.. (2026). [Application of transcatheter edge-to-edge repair in the treatment of papillary muscle rupture of mitral valve after acute myocardial infarction].. Zhonghua xin xue guan bing za zhi. https://doi.org/10.3760/cma.j.cn112148-20250128-00076